MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5.

Slides:

Advertisements

Similar presentations

Dr. Essam El Moghazy NTP Egypt

Advertisements

12-1 Chapter 12 Advanced EHR Functionality © 2012 The McGraw-Hill Companies, Inc. All rights reserved. McGraw-Hill.

Contact Evaluation Your name Institution/organization Meeting Date International Standard 16.

Contact Evaluation Your name Institution/organization Meeting Date International Standards 18, 19.

ISTC Training Modules 2008 Your name Institution/organization Meeting Date.

Your name Institution/organization Meeting Date. Introduction.

Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13

Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13

Contact Investigation for Tuberculosis Control

ALGEBRAIC EXPRESSIONS

DIVIDING INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.

MULTIPLYING MONOMIALS TIMES POLYNOMIALS (DISTRIBUTIVE PROPERTY)

ADDING INTEGERS 1. POS. + POS. = POS. 2. NEG. + NEG. = NEG. 3. POS. + NEG. OR NEG. + POS. SUBTRACT TAKE SIGN OF BIGGER ABSOLUTE VALUE.

SUBTRACTING INTEGERS 1. CHANGE THE SUBTRACTION SIGN TO ADDITION

MULT. INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.

Unit 1. Introduction TB Infection Control Training for Managers at the National and Subnational Levels.

Course Goal To improve the TB contact investigation interviewing skills of health care workers 2.

A typical day in the TB clinic You see the following patients in the TB clinic. All have normal CXRs: 1. A 35 year old man from Hartford with a 16 mm positive.

© S Haughton more than 3?

MDR-TB GLOBALLY AND IN THE REGION 2013 Dr Samiha Baghdadi Medical officer – STB WHO – EMRO Cairo March 2014.

National Tuberculosis Controllers Association

June 2004 HITCH Training Slide Set #3 Special Considerations in Antiretroviral Therapy.

Managing Health Data Systems: Training on MiMOSA Medical Module Opening Meeting 1. Medical Data Processing 2. Mission-Specific Settings 3. Non-USRP Processing.

Health Assessment Abnormal Cases. Objective Review Health Assessment Status transitions for abnormal cases Record HA (Health Assessment) Results for an.

Health Assessment Normal Cases and Results. Objective Understand the updates of the US2014 form on the list of medical services in the Summary tab of.

Squares and Square Root WALK. Solve each problem REVIEW:

Past Tense Probe. Past Tense Probe Past Tense Probe – Practice 1.

TREATMENT OF TUBERCULOSIS, 2003

Country Update: Tuberculosis in Thailand

1 First EMRAS II Technical Meeting IAEA Headquarters, Vienna, 19–23 January 2009.

Addition 1’s to 20.

25 seconds left…...

Test B, 100 Subtraction Facts

WORKSHOP FOR INTERNATIONAL STUDENTS CONDUCTED BY THE INTERNATIONAL CENTER APRIL 8, 2011 APRIL 11, 2011 APRIL 15, 2011 APRIL18, 2011 MyCSN Student Information.

Tuberculosis in Children: Prevention Module 10C - March 2010.

Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.

World Health Organization TB Case Definitions

CDC Update on the 2007 TB Technical Instructions Sharmila Shetty, MD Immigrant, Refugee & Migrant Health Branch Division of Global Migration and Quarantine.

International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo.

Dr. Raz Mohammed WALI Chief Migration Health Physician NTP National Seminar: July 2014 Pukhra, Nepal.

Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.

Diagnosis of TB.

Tuberculosis Follow up Care PA Department of Health Role Maxine Kopiec Community Health Nursing Supervisor April 24, 2015.

Plans for Diagnosis and Management of Acute Pyelonephritis.

Evaluating Tuberculosis Surveillance and Action in an Urban and Rural Setting Kristine Lykens, Ph.D. In collaboration with Anita Kurian, MPH, MBBS Patrick.

Colorado Department of Public Health and Environment Tuberculosis Prevention and Control Program.

Progress of the Singapore TB Elimination Programme (STEP)

V IRGINIA C OHORT D ATA – 5 YEAR TRENDS AFTER 4 YEARS OF LOCAL COHORT REVIEW Virginia achievement on National TB Indicators for the past 5 years – where.

Unit 12: Reporting & Recording Botswana National Tuberculosis Programme Manual Training for Medical Officers.

Screening for TB.

بسم الله الرحمن الرحيم. A 25 year old Saudi male applied to work as paramedic. He has no symptoms or history of contact with sick patients. His physical.

Extrapulmonary Site 2 :_____________________ TUBERCULOSIS TREATMENT CARD BOTSWANA NATIONAL TUBERCULOSIS PROGRAMME Date RegisteredIN ToOUT RegisteredIN.

CDC Guidelines for Use of QuantiFERON ® -TB Gold Test Philip LoBue, MD Centers for Disease Control and Prevention Division of Tuberculosis Elimination.

California Update : TB Epidemiology and Indicators CTCA October 22, 2010 Jennifer Flood MD MPH Chief, Surveillance and Epidemiology Tuberculosis Control.

Unit 11 Drug Resistance and MDR-TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.

Tuberculosis in Children and Young Adults

Roundtable. Detection and treatment of TB Andrew Black.

Depart. of Pulmonology 백승숙. More than 80% of cases of tuberculosis in the United States –The result of reactivated latent infection –Nearly all these.

US TB Treatment Guidelines and DOT

Screening International Adoptees

Zachary White, MPH Drew L. Posey, MD, MPH

Epidemiology of pulmonary tuberculosis

Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors

اهمیت سل در چیست؟ حدود یک سوم جمعیت جهان(2 میلیارد نفر)با میکروب سل آلوده شده اند سالانه 9 میلیون نفر به سل فعال مبتلا می شوند هر ساله 1/5 تا 2 میلیون.

CDC Guidelines for Use of QuantiFERON®-TB Gold Test

بسم الله الرحمن الرحيم.

Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors

Presentation transcript:

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting TB Evaluation and Treatment Workflows and the 2007 DS Forms 2 2

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting Tuberculosis Evaluation Screening medical examination for tuberculosis may consist of: Medical history Physical examination Chest radiography Tuberculin skin testing / IGRA HIV testing Sputum smear, culture and DST testing

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting TB Screening Workflow Source: CDC TB Technical Instructions 2007 *In countries with WHO-estimated TB incidence of >20 cases per 100,000

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting < 10 mm> 10 mm TB Screening Workflow

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting LTBI Evaluation Source: Presentation of Dr. Mary Naughton, CDC, during US Panel Physician’s Summit, April 2009 TST < 10mmTST > 10mm

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting LTBI Before No field specified for entering TST result in current DS form TST result captured in WRx module WRx data entryWRx printout

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting LTBI After (2007 DS) LTBI evaluation data must be entered in DS-2054

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting Contact Evaluation Source: US Panel Physician’s Training Summit Workbook, April 2009

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting Contact Before No field specified for entering contact evaluation results Use WRx Contact Evaluation Form

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting Contact After (2007 DS) Contact evaluation data must be entered in DS- 2054

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting Current vs New (2007) DS Forms OLD 1991 DS UPDATED 1991 DS 2007 DS Classification / Summary Sheet DS-2053DS-2053 (updated)DS-2054 (new) CXR Worksheet DS-3024DS-3024 (updated)DS-3030 (new) Vaccination Worksheet DS-3025DS 3025 (updated) History and PE Worksheet DS-3026DS 3026 (updated)

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting DS-3030 (New CXR Form) – 1 What’s New?  Positive TST result is listed as an indication for CXR

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting What’s New?  Table is provided for entering sputum culture results DS-3030 (New CXR Form) – 2

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting What’s New?  Classification list is expanded and includes LTBI and Contact DS-3030 (New CXR Form) – 3

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting TB Class: 1991 vs 2007 Source: Presentation of Dr. Mary Naughton, CDC, during US Panel Physician’s Summit, April 2009

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting TB Class: 1991 vs 2007 Source: Presentation of Dr. Mary Naughton, CDC, during US Panel Physician’s Summit, April 2009

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting Classification Before (DS 2053) Limited classification options Use WRx Pre- departure TB Classification Form

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting Classification After (DS 2054)

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting Validity Periods: 1991 TI Source: Presentation of Dr. Mary Naughton, CDC, during US Panel Physician’s Summit, April 2009

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting Validity Periods: 2007 TI Source: Presentation of Dr. Mary Naughton, CDC, during US Panel Physician’s Summit, April 2009

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting TB Rx, Patients (DS) Class A-Applicants who have positive sputum smears should not be cleared for travel and should be treated for TB, unless culture is found to be negative. -Applicants who have negative sputum smears and positive cultures should not be cleared for travel and should be treated for TB. Class B1 with advanced findings Must complete DOT prior to immigration Class B2 ( LTBI) In general, preventive treatment should not be initiated overseas (unless pediatric contact or impaired immunity) Class B3 ( Contact) -Contacts diagnosed with TB disease will need to complete treatment prior to immigration. -If negative for TB disease: In general, preventive treatment should not be initiated overseas (unless pediatric contact or impaired immunity)

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting TB Rx, patients (WHO) New TB case – A/B1 – LTBI Rx – Contact Rx Rx after default Rx after failure Transfer In Relapse Other

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting TB Treatment, Overview TB Dx Cat-ry TB patients TB treatment regimens Initial phase Continuation phase INew smear-positive patients. New smear-negative PTB Severe concomitant HIV disease or severe forms of ext- PTB. 2HRZEb4HR (or 6HE daily) IIRelapse, treatment after default, treatment failure. 2HRZES/ 1HRZE 5HRE IIINew smear-negative pulmonary TB (other than in Category I). Less severe forms of ext-PTB. 2HRZEe4HR (or 6HE dailyc) IVChronic and MDR-TB cases (still sputum-positive after supervised re-treatment)f. Specially designed individualized or standardized regimens are suggested (WHO guidelines, Ch. 5)

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting TB Rx, Monitoring – 1 Side effects captured in WRx follow-up exam form

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting TB Rx, Monitoring – 2 Laboratory tests captured in WRx module WRx data entry WRx printout WRx data entry

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting TB Rx Recording – 1 DS-2053 / DS-2054 captures treatment regimen

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting TB Rx Recording – 2 Rx outcome captured in WRx exit exam form

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting Pre-departure Exam Performed on applicants with equivocal results (history, PE, CXR suggestive of TB but no positive sputum smear or culture) Consists of history, PE, CXR and 3 sputum smear specimens (no cultures required) Conducted within 3 weeks prior to departure If results are negative, Class B1 TB, Pulmonary

MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5. Exercises (new DS) 6. Issues with new DS 7. Overview of WRx module 8. Data entry for TB WRx scenarios 9. WRx reports 10. Exercises (WRx) 11. WRx module admin & maint. 12. Exercises (WRx admin & maint) 13. Issues with WRx 14. Other MiMOSA features 15. Program evaluation indicators 16. Other systems 17. Change request 18. Final meeting References American Thoracic Society, CDC and Infectious Diseases Society of America. Treatment of Tuberculosis. June 2003 Centers for Disease Control and Prevention. CDC Immigration Requirements: Technical Instructions for Tuberculosis Screening and Treatment Using Cultures and Directly Observed Therapy (DRAFT). June 2009 US Panel Physicians Training Summit Workbook. April 2009